Control and clodronate liposomes were purchased from Liposoma Research. The right flank was shaved, and 50 µl of control liposomes (containing PBS) (PBS-L) or clodronate liposomes (CLL) was intradermally injected 7 days prior to tumor implantation. Liposomes were then injected weekly to maintain macrophage depletion. For systemic CLL treatment, 200 µl of control PBS-L or CLL were injected intraperitoneally (i.p.) 7 days prior to tumor implantation and then weekly to maintain macrophage depletion.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.